An aminosalicylate drug used for the treatment of mild to moderate ulcerative colitis and the maintenance of remission.
This medication is employed to decrease inflammation in the intestines for individuals with ulcerative colitis. It can be recommended to alleviate symptoms during sudden flare-ups or taken as a preventive approach. Undesirable outcomes of mesalazine encompass feelings of nausea, diarrhea, abdominal discomfort, and headaches.